279
Views
0
CrossRef citations to date
0
Altmetric
EXPERT OPINION

Management of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in the Pan-Arab Region: Consensus Recommendations from a Multidisciplinary Expert Working Group

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1055-1063 | Received 22 Mar 2023, Accepted 14 Sep 2023, Published online: 29 Sep 2023

References

  • Klonaris D, Doulaptsi M, Karatzanis A, Velegrakis S, Milioni A, Prokopakis E. Assessing quality of life and burden of disease in chronic rhinosinusitis: a review. Rhinol Online. 2019;2:6–13. doi:10.4193/RHINOL/18.067
  • Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(S29):1–464. doi:10.4193/Rhin20.600
  • Fokkens WJ, Lund VJ, Hopkins C, et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020;58(2):82–111. doi:10.4193/Rhin20.601
  • Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP. Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract. 2021;9(3):1133–1141. doi:10.1016/j.jaip.2020.09.063
  • Hopkins C. Chronic rhinosinusitis with nasal polyps. N Engl J Med. 2019;381(1):55–63. doi:10.1056/NEJMcp1800215
  • Bachert C, Marple B, Hosemann W, Cavaliere C, Wen W, Zhang N. Endotypes of chronic rhinosinusitis with nasal polyps: pathology and possible therapeutic implications. J Allergy Clin Immunol Pract. 2020;8(5):1514–1519. doi:10.1016/j.jaip.2020.03.007
  • Kowalski ML, Agache I, Bavbek S, et al. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-A EAACI position paper. Allergy. 2019;74(1):28–39. doi:10.1111/all.13599
  • Rudmik L, Soler ZM, Hopkins C, et al. Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness study. Rhinology. 2016;54(2):117–128. doi:10.4193/Rhino16.023
  • Beswick DM, Mace JC, Soler ZM, et al. Appropriateness criteria predict outcomes for sinus surgery and may aid in future patient selection. Laryngoscope. 2018;128(11):2448–2454. doi:10.1002/lary.27227
  • Loftus CA, Soler ZM, Koochakzadeh S, et al. Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors. Int Forum Allergy Rhinol. 2020;10(2):199–207. doi:10.1002/alr.22487
  • Loftus CA, Soler ZM, Desiato VM, et al. Factors impacting revision surgery in patients with chronic rhinosinusitis with nasal polyposis. Int Forum Allergy Rhinol. 2020;10(3):289–302. doi:10.1002/alr.22505
  • Fokkens WJ, Lund V, Bachert C, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019;74(12):2312–2319. doi:10.1111/all.13875
  • Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021;147(1):29–36. doi:10.1016/j.jaci.2020.11.013
  • Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213–739. doi:10.1002/alr.22741
  • Alsaleh S, Alqahtani A, Alotaibi N, et al. The use of biologics in chronic rhinosinusitis with polyps: Saudi otorhinolaryngology society position statement. Saudi J Otorhinolaryngol Head Neck Surg. 2020;22(2):93–94. doi:10.4103/SJOH.SJOH_29_20
  • Al-Ahmad M, Alsaleh S, Al-Reefy H, et al. Expert opinion on biological treatment of chronic rhinosinusitis with nasal polyps in the gulf region. J Asthma Allergy. 2022;15:1–12. doi:10.2147/JAA.S321017
  • Dietz de Loos DA, Hopkins C, Fokkens WJ. Symptoms in chronic rhinosinusitis with and without nasal polyps. Laryngoscope. 2013;123(1):57–63. doi:10.1002/lary.23671
  • Passali D, Cingi C, Cambi J, Passali F, Muluk NB, Bellussi ML. A survey on chronic rhinosinusitis: opinions from experts of 50 countries. Eur Arch Otorhinolaryngol. 2016;273(8):2097–2109. doi:10.1007/s00405-015-3880-6
  • Kim DH, Seo Y, Kim KM, Lee S, Hwang SH. Usefulness of nasal endoscopy for diagnosing patients with chronic rhinosinusitis: a meta-analysis. Am J Rhinol Allergy. 2020;34(2):306–314. doi:10.1177/1945892419892157
  • Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol. 2013;131(1):110–6 e1. doi:10.1016/j.jaci.2012.07.047
  • Hopkins C, Browne JP, Slack R, Lund V, Brown P. The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict? Otolaryngol Head Neck Surg. 2007;137(4):555–561. doi:10.1016/j.otohns.2007.02.004
  • Cho SH, Hamilos DL, Han DH, Laidlaw TM. Phenotypes of chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2020;8(5):1505–1511. doi:10.1016/j.jaip.2019.12.021
  • Jarvis D, Newson R, Lotvall J, et al. Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy. 2012;67(1):91–98. doi:10.1111/j.1398-9995.2011.02709.x
  • Castagnoli R, Licari A, Brambilla I, Tosca M, Ciprandi G, Marseglia GL. An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma. Expert Rev Respir Med. 2020;14(12):1197–1205. doi:10.1080/17476348.2020.1812388
  • Philpott CM, Erskine S, Hopkins C, et al. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK national chronic rhinosinusitis epidemiology study. Respir Res. 2018;19(1):129. doi:10.1186/s12931-018-0823-y
  • Crimi C, Campisi R, Nolasco S, et al. Type 2-high severe asthma with and without bronchiectasis: a prospective observational multicentre study. J Asthma Allergy. 2021;14:1441–1452. doi:10.2147/JAA.S332245
  • Agache I, Song Y, Alonso-Coello P, et al. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines. Allergy. 2021;76(8):2337–2353. doi:10.1111/all.14809
  • Fokkens W, Van Der Lans R, Reitsma S. Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis. Expert Opin Biol Ther. 2021;21(5):575–585. doi:10.1080/14712598.2021.1901881
  • Bachert C, Zhang N, Cavaliere C, Weiping W, Gevaert E, Krysko O. Biologics for chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2020;145(3):725–739. doi:10.1016/j.jaci.2020.01.020
  • Laury AM, Wise SK. Chapter 7: allergic fungal rhinosinusitis. Am J Rhinol Allergy. 2013;27(1):S26–7. doi:10.2500/ajra.2013.27.3891
  • Bulkhi AA, Mirza AA, Aburiziza AJ, Marglani OA. Dupilumab: an emerging therapy in allergic fungal rhinosinusitis. World Allergy Organ J. 2022;15(3):100638. doi:10.1016/j.waojou.2022.100638
  • Steehler AJ, Vuncannon JR, Wise SK, DelGaudio JM. Central compartment atopic disease: outcomes compared with other subtypes of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2021;11(11):1549–1556. doi:10.1002/alr.22819
  • Lal D, Borish L, Detwiller KY, et al. The rationale for multidisciplinary management of chronic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol Pract. 2020;8(5):1565–1566. doi:10.1016/j.jaip.2020.03.001
  • Han JK, Bosso JV, Cho SH, et al. Multidisciplinary consensus on a stepwise treatment algorithm for management of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2021;11(10):1407–1416. doi:10.1002/alr.22851
  • Alfallaj R, Obaid SB, Almousa H, et al. Demographic and clinical profile of patients with chronic rhinosinusitis in Saudi Arabia. Saudi Med J. 2023;44(4):401–405. doi:10.15537/smj.2023.44.4.20220947
  • Fokkens WJ, Lund V, Luong AU, Orlandi RR. A Comparison of International Guidelines for Rhinosinusitis. J Allergy Clin Immunol Pract. 2022;10(6):1418–1422. doi:10.1016/j.jaip.2022.01.013
  • Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item sinonasal outcome test. Clin Otolaryngol. 2009;34(5):447–454. doi:10.1111/j.1749-4486.2009.01995.x
  • Toma S, Hopkins C. Stratification of SNOT-22 scores into mild, moderate or severe and relationship with other subjective instruments. Rhinology. 2016;54(2):129–133. doi:10.4193/Rhino15.072
  • Alanazy F, Dousary SA, Albosaily A, Aldriweesh T, Alsaleh S, Aldrees T. Psychometric Arabic sino-nasal outcome test-22: validation and translation in chronic rhinosinusitis patients. Ann Saudi Med. 2018;38(1):22–27. doi:10.5144/0256-4947.2018.22
  • Hopkins C, Rudmik L, Lund VJ. The predictive value of the preoperative Sinonasal Outcome Test-22 score in patients undergoing endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope. 2015;125(8):1779–1784. doi:10.1002/lary.25318
  • Chowdhury NI, Mace JC, Bodner TE, et al. Does medical therapy improve sinonasal outcomes test-22 domain scores? An analysis of clinically important differences. Laryngoscope. 2019;129(1):31–36. doi:10.1002/lary.27470
  • Soler ZM, Kohli P, Storck KA, Schlosser RJ. Olfactory impairment in chronic rhinosinusitis using threshold, discrimination, and identification scores. Chem Senses. 2016;41(9):713–719. doi:10.1093/chemse/bjw080
  • Bachert C, Zhang L, Gevaert P. Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis. J Allergy Clin Immunol. 2015;136(6):1431–1440. doi:10.1016/j.jaci.2015.10.010
  • Neubauer PD, Schwam ZG, Manes RP. Comparison of intranasal fluticasone spray, budesonide atomizer, and budesonide respules in patients with chronic rhinosinusitis with polyposis after endoscopic sinus surgery. Int Forum Allergy Rhinol. 2016;6(3):233–237. doi:10.1002/alr.21688
  • Grayson JW, Harvey RJ. Topical corticosteroid irrigations in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019;9(S1):S9–S15. doi:10.1002/alr.22331
  • Head K, Chong LY, Hopkins C, Philpott C, Schilder AG, Burton MJ. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:CD011992. doi:10.1002/14651858.CD011992.pub2
  • Hox V, Lourijsen E, Jordens A, et al. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clin Transl Allergy. 2020;10:1. doi:10.1186/s13601-019-0303-6
  • Weber RK, Hosemann W. Comprehensive review on endonasal endoscopic sinus surgery. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2015;14:Doc08. doi:10.3205/cto000123
  • Gill AS, Smith KA, Meeks H, et al. Asthma increases long-term revision rates of endoscopic sinus surgery in chronic rhinosinusitis with and without nasal polyposis. Int Forum Allergy Rhinol. 2021;11(8):1197–1206. doi:10.1002/alr.22779
  • Laidlaw TM, Buchheit KM. Biologics in chronic rhinosinusitis with nasal polyposis. Ann Allergy Asthma Immunol. 2020;124(4):326–332. doi:10.1016/j.anai.2019.12.001
  • Mullol J, Azar A, Buchheit KM, Hopkins C, Bernstein JA. Chronic rhinosinusitis with nasal polyps: quality of life in the biologics era. J Allergy Clin Immunol Pract. 2022;10(6):1434–1453.
  • Anselmo-Lima WT, Tamashiro E, Romano FR, et al. Guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps (CRSwNP) in Brazil. Braz J Otorhinolaryngol. 2021;88(3):471–480. doi:10.1016/j.bjorl.2021.03.003
  • Fokkens WJ, Viskens AS, Backer V, et al. EPOS/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023. Rhinology. 2023;61(3):194–202. doi:10.4193/Rhin22.489